vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and REGIS CORP (RGS). Click either name above to swap in a different company.
REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $44.5M, roughly 1.3× Cronos Group Inc.). REGIS CORP runs the higher net margin — 0.8% vs -4.1%, a 4.9% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs 22.3%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $891.0K). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 7.8%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
CRON vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $57.1M |
| Net Profit | $-1.8M | $456.0K |
| Gross Margin | 36.4% | — |
| Operating Margin | -16.8% | 10.8% |
| Net Margin | -4.1% | 0.8% |
| Revenue YoY | 47.0% | 22.3% |
| Net Profit YoY | -104.2% | -94.0% |
| EPS (diluted) | $-0.01 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $57.1M | ||
| Q3 25 | $36.3M | $59.0M | ||
| Q2 25 | $33.5M | $60.4M | ||
| Q1 25 | $32.3M | $57.0M | ||
| Q4 24 | $30.3M | $46.7M | ||
| Q3 24 | $34.3M | $46.1M | ||
| Q2 24 | $27.8M | $49.4M | ||
| Q1 24 | $25.3M | $49.2M |
| Q4 25 | $-1.8M | $456.0K | ||
| Q3 25 | $26.0M | $1.4M | ||
| Q2 25 | $-39.7M | $116.5M | ||
| Q1 25 | $6.1M | $250.0K | ||
| Q4 24 | $43.7M | $7.6M | ||
| Q3 24 | $8.3M | $-853.0K | ||
| Q2 24 | $-8.8M | $91.2M | ||
| Q1 24 | $-2.2M | $-2.3M |
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
| Q4 25 | -16.8% | 10.8% | ||
| Q3 25 | -1.4% | 10.0% | ||
| Q2 25 | -15.9% | 12.1% | ||
| Q1 25 | -12.6% | 8.8% | ||
| Q4 24 | -37.5% | 11.8% | ||
| Q3 24 | -98.2% | 4.6% | ||
| Q2 24 | -56.1% | — | ||
| Q1 24 | -63.1% | 8.3% |
| Q4 25 | -4.1% | 0.8% | ||
| Q3 25 | 71.4% | 2.3% | ||
| Q2 25 | -118.7% | 192.9% | ||
| Q1 25 | 19.0% | 0.4% | ||
| Q4 24 | 144.3% | 16.4% | ||
| Q3 24 | 24.4% | -1.9% | ||
| Q2 24 | -31.5% | 184.7% | ||
| Q1 24 | -8.9% | -4.7% |
| Q4 25 | $-0.01 | $0.16 | ||
| Q3 25 | $0.07 | $0.49 | ||
| Q2 25 | $-0.10 | $43.67 | ||
| Q1 25 | $0.02 | $0.08 | ||
| Q4 24 | $0.12 | $2.71 | ||
| Q3 24 | $0.02 | $-0.36 | ||
| Q2 24 | $-0.02 | $38.40 | ||
| Q1 24 | $-0.01 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $18.4M |
| Total DebtLower is stronger | — | $113.3M |
| Stockholders' EquityBook value | $1.1B | $188.7M |
| Total Assets | $1.2B | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $18.4M | ||
| Q3 25 | $824.2M | $16.6M | ||
| Q2 25 | $834.4M | $17.0M | ||
| Q1 25 | $837.8M | $13.3M | ||
| Q4 24 | $858.8M | $10.2M | ||
| Q3 24 | $862.0M | $6.3M | ||
| Q2 24 | $848.2M | $10.1M | ||
| Q1 24 | $855.1M | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
| Q4 25 | $1.1B | $188.7M | ||
| Q3 25 | $1.1B | $187.6M | ||
| Q2 25 | $1.1B | $185.6M | ||
| Q1 25 | $1.1B | $68.6M | ||
| Q4 24 | $1.1B | $66.7M | ||
| Q3 24 | $1.1B | $56.4M | ||
| Q2 24 | $1.1B | $56.8M | ||
| Q1 24 | $1.1B | $-35.8M |
| Q4 25 | $1.2B | $588.3M | ||
| Q3 25 | $1.2B | $592.1M | ||
| Q2 25 | $1.2B | $599.0M | ||
| Q1 25 | $1.2B | $511.2M | ||
| Q4 24 | $1.2B | $530.1M | ||
| Q3 24 | $1.2B | $508.9M | ||
| Q2 24 | $1.1B | $530.5M | ||
| Q1 24 | $1.1B | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $1.7M |
| Free Cash FlowOCF − Capex | $9.7M | $891.0K |
| FCF MarginFCF / Revenue | 21.8% | 1.6% |
| Capex IntensityCapex / Revenue | 4.8% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $1.7M | ||
| Q3 25 | $13.3M | $2.3M | ||
| Q2 25 | $2.8M | $6.8M | ||
| Q1 25 | $-2.1M | $6.2M | ||
| Q4 24 | $7.7M | $2.1M | ||
| Q3 24 | $11.6M | $-1.3M | ||
| Q2 24 | $1.7M | $5.1M | ||
| Q1 24 | $-2.2M | $-277.0K |
| Q4 25 | $9.7M | $891.0K | ||
| Q3 25 | $8.8M | $1.9M | ||
| Q2 25 | $-1.0M | $6.2M | ||
| Q1 25 | $-17.4M | $5.9M | ||
| Q4 24 | $4.2M | $1.7M | ||
| Q3 24 | $5.2M | $-1.4M | ||
| Q2 24 | $1.0M | $5.1M | ||
| Q1 24 | $-3.9M | $-326.0K |
| Q4 25 | 21.8% | 1.6% | ||
| Q3 25 | 24.3% | 3.2% | ||
| Q2 25 | -3.0% | 10.3% | ||
| Q1 25 | -53.8% | 10.3% | ||
| Q4 24 | 13.8% | 3.6% | ||
| Q3 24 | 15.1% | -3.0% | ||
| Q2 24 | 3.7% | 10.3% | ||
| Q1 24 | -15.5% | -0.7% |
| Q4 25 | 4.8% | 1.4% | ||
| Q3 25 | 12.3% | 0.7% | ||
| Q2 25 | 11.5% | 0.9% | ||
| Q1 25 | 47.3% | 0.6% | ||
| Q4 24 | 11.7% | 0.9% | ||
| Q3 24 | 18.7% | 0.0% | ||
| Q2 24 | 2.6% | 0.0% | ||
| Q1 24 | 6.8% | 0.1% |
| Q4 25 | — | 3.65× | ||
| Q3 25 | 0.51× | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | -0.34× | 24.80× | ||
| Q4 24 | 0.18× | 0.28× | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
